Neogen appoints QIAGEN CEO Thierry Bernard to board of directors

NEOGEN CORP

Thierry Bernard appointed to Neogen Board of Directors, effective November 1, 2024.
Bernard is CEO of QIAGEN N.V. (NYSE: QGEN), a global molecular insights provider.
Bernard previously held senior roles at bioMérieux SA over 15 years.
Board determined Bernard qualifies as independent under Nasdaq listing standards.
Board Chair Jim Borel highlighted Bernard's science and technology expertise.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thierry Bernard

Director

NEOG · NEOGEN CORP

Effective: 2024-11-01
Filed: October 1, 2024, 7:59 PM ET

Neogen Corporation announced today that it has appointed Thierry Bernard to its Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thierry Bernard was appointed as Director at NEOGEN CORP.

Action: appointed
Role: Director

Exact text from the filing

Neogen Corporation announced today that it has appointed Thierry Bernard to its Board of Directors.

View on SEC.gov

NEOGEN CORP filing history →

Source: SEC EDGAR

accession 0000950170-24-110564

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.